Development of sarcoidosis during etanercept therapy

被引：83

作者：

Gonzalez-Lopez, Marcos A. ^{[1
]}

Blanco, Ricardo ^{[1
]}

Gonzalez-Vela, M. Carmen ^{[1
]}

Fernandez-Llaca, Hector ^{[1
]}

Rodriguez-Valverde, Vicente ^{[1
]}

机构：

[1] Univ Cantabria, Fac Med, Hosp Marques Valdecilla, Rheumatol Serv, Santander 39008, Spain

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2006年 / 55卷 / 05期

关键词：

D O I：

10.1002/art.22238

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：817 / 820

页数：4

共 20 条

[1]

*COM EXP SER, 2002, REV ESP REUMATOL, V29, P51

[2] Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis [J].

Cunnane, G ;

Warnock, M ;

Fye, KH ;

Daikh, DI .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (04) :445-449

[3]

Dinarello CA, 2005, J RHEUMATOL, V32, P40

[4] Treatment of sarcoidosis with infliximab [J].

Doty, JD ;

Mazur, JE ;

Judson, MA .

CHEST, 2005, 127 (03) :1064-1071

[5]

Ehlers S, 2005, J RHEUMATOL, V32, P35

[6] Differentiating the efficacy of the tumor necrosis factor inhibitors [J].

Haraoui, B .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :7-11

[7] Chronic sarcoid arthritis treated with intraarticular etanercept [J].

Hobbs, Kathryn .

ARTHRITIS AND RHEUMATISM, 2005, 52 (03) :987-988

[8] Pulmonary rheumatoid nodules in an etanercept-treated patient [J].

Hübscher, O ;

Re, R ;

Iotti, R .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :2077-2078

[9] The etiologic agent of sarcoidosis - What if there isn't one? [J].

Judson, MA .

CHEST, 2003, 124 (01) :6-8

[10] Development of rheumatoid nodules during anti-tumor necrosis factor α therapy with etanercept [J].

Kekow, J ;

Welte, T ;

Kellner, U ;

Pap, T .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :843-844

← 1 2 →